Skip to main content
. 2020 Jul 8;20(3):257–266. doi: 10.1007/s40268-020-00315-2

Table 4.

Covariate analysis with the best POPPK base model

Covariate  − 2LL AIC p value
Albumin on CL 915.873 935.948 0.33
Albumin on V 922.736 938.562 0.35
Total protein on CL 918.645 936.934 0.27
Total protein on V 917.374 937.487 0.22
Creatinine on CL 861.734 877.734 0.035
Creatinine on V 893.437 926.475 0.25
Age on CL 879.374 901.573 0.071
Age on V 894.571 913.846 0.13
Weight on CL 886.478 903.478 0.24
Weight on V 861.734 877.734 0.009
Comorbidities on CL 920.479 940.734 0.42
Comorbidities on V 912.873 937.493 0.39
Concomitant use of other drugs on CL 893.468 932.477 0.40
Concomitant use of other drugs on V 927.547 940.750 0.62

AIC Akaike information criteria, CL clearance, POPPK population pharmacokinetic, V distribution volume, − 2LL − 2 × log-likelihood